Endoscopic case

Endoscopic case

We present the case of a ten-year-old female patient referred to Gastroenterolgy consultation for abdominal pain and cramping, usually worse after eating, recurring diarrhoea, hypochromic and microcytic anaemia with low serum iron and ferritin levels. Moderate to severe Crohn’s disease of the termin...

Full description

Bibliographic Details
Main Author:	Fernando Pereira
Format:	Article
Language:	English
Published:	Centro Hospitalar do Porto 2017-01-01
Series:	Nascer e Crescer
Subjects:	Anemia Doença de Crohn Infliximab
Online Access:	http://revistas.rcaap.pt/nascercrescer/article/view/10669

Similar Items

Doença de Crohn = efeito de um concentrado de proteínas do soro de leite bovino enriquecido com tgf-ß na nutrição e inflamação de pacientes sob terapia com imunossupressor
by: Davanço, Taciana
Published: (2011)

SERUM INFLIXIMAB MEASUREMENT IN INFLAMMATORY BOWEL DISEASE PATIENTS IN REMISSION: A COMPARATIVE ANALYSIS OF TWO DIFFERENT METHODS IN A MULTICENTRIC BRAZILIAN COHORT
by: Fábio Vieira TEIXEIRA, et al.

Adenocarcinoma de recto y ano en paciente con enfermedad de Crohn tratado con infliximab Adenocarcinoma of the rectum and anus in a patient with Crohn´s disease treated with infliximab
by: J. Egea Valenzuela, et al.
Published: (2010-08-01)

Anti-TNF treatment and miliary tuberculosis in Crohn’s disease
by: Milenković Branislava, et al.
Published: (2011-01-01)

Long-Term Clinical Outcomes of Korean Patient With Crohn's Disease Following Early Use of Infliximab
by: Nam Hee Kim, et al.
Published: (2014-10-01)

Refractory Duodenal Crohn's Disease Successfully Treated with Infliximab
by: You Lim Kim, et al.
Published: (2014-01-01)

Early intestinal obstruction after infliximab therapy in Crohn’s disease
by: Mitsuro Chiba, et al.
Published: (2019-08-01)

Successful Treatment of Postoperative Fistula with Infliximab in a Patient with Crohn's Disease
by: Seong Yeon Jeong, et al.
Published: (2014-01-01)

Crohn S Disease and Acne Fulminans as Associated Disoders (Case Report)
by: Pecova K, et al.
Published: (2015-09-01)

Infliximab‐induced seizures in a patient with Crohn’s disease: a case report
by: Zhijie Lv, et al.
Published: (2021-04-01)

EFFICACY OFINFLIXIMABIN THE TREATMENTOF CROHN’S DISEASEIN CHILDREN
by: E. G. Tsimbalova, et al.
Published: (2012-01-01)

Crohn’s Disease with Atypical Extra-Intestinal Manifestations Developing Under Treatment with Vedolizumab
by: Aasem Abu Shtaya, et al.
Published: (2021-02-01)

Retreatment and maintenance therapy with infliximab in fistulizing Crohn' disease Retratamiento y tratamiento de mantenimiento con infliximab en la enfermedad de Crohn fistulizante
by: L. Rodrigo, et al.
Published: (2004-08-01)

Efficacy of adalimumab in patients with crohn's disease and failure to infliximab therapy: a clinical series Eficacia de Adalimumab en pacientes con enfermedad de Crohn y fracaso previo a la terapia con Infliximab: resultados de una serie clínica
by: Patricia Cordero-Ruiz, et al.
Published: (2011-06-01)

Treatment of orofacial granulomatosis: a case report
by: Maaz B. Badshah, et al.
Published: (2017-10-01)

Predictors of response to infliximab in patients with fistulizing Crohn's disease Factores predictivos de respuesta a infliximab en pacientes con enfermedad de Crohn fistulizante
by: M. Luna-Chadid, et al.
Published: (2004-06-01)

Systemic Lupus Erythematosus with Crohn’s Disease: A Rare Combination and Unusual Presentation
by: Abdulrahman Algassim, et al.
Published: (2021-06-01)

Loss of Response to Long-Term Infliximab Therapy in Children with Crohn’s Disease
by: George Alex, et al.
Published: (2013-10-01)

Decrease in Mucosal IL17A, IFNγ and IL10 Expressions in Active Crohn’s Disease Patients Treated with High-Dose Vitamin Alone or Combined with Infliximab
by: Mia Bendix, et al.
Published: (2020-11-01)

Clinical efficacy of adalimumab versus infliximab and the factors associated with recurrence or aggravation during treatment of anal fistulas in Crohn's disease
by: Cheng-Chun Ji, et al.
Published: (2017-04-01)

Serum Levels of Infliximab and Anti-Infliximab Antibodies in Brazilian Patients with Crohn’s Disease
by: Luis Eduardo Miani Gomes, et al.
Published: (2019-04-01)

Seven Weeks of High-Dose Vitamin D Treatment Reduces the Need for Infliximab Dose-Escalation and Decreases Inflammatory Markers in Crohn’s Disease during One-Year Follow-Up
by: Mia Bendix, et al.
Published: (2021-03-01)

Cortical Vein Thrombosis after Infliximab Treatment for Crohn’s Disease
by: Saeed Razmeh, et al.
Published: (2021-03-01)

ADALIMUMAB INDUCTION AND MAINTAINING REMISSION FOR CROHN’S DISEASE IN PATIENT WHO LOST RESPONSE TO INFLIXIMAB. Case report
by: Ivaylo Vazharov, et al.
Published: (2016-12-01)

Trough level of infliximab is useful for assessing mucosal healing in Crohn's disease: a prospective cohort study
by: Akihiro Koga, et al.
Published: (2018-04-01)

Mais do que uma anemia ferropénica
by: J. Carvalho, et al.
Published: (2018-06-01)

Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn’s disease
by: Yizhong Wang, et al.
Published: (2021-01-01)

Women respond better to biological therapy in Crohn's Disease
by: Carlos Henrique Marques dos Santos

Infliximab‐induced autoimmune hepatitis requiring liver transplantation
by: Frederick Wong, et al.
Published: (2019-11-01)

Long-term prognosis of Japanese patients with biologic-naïve Crohn’s disease treated with anti-tumor necrosis factor-α antibodies
by: Rintaro Moroi, et al.
Published: (2019-01-01)

Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn’s disease
by: Matsumoto S, et al.
Published: (2018-07-01)

Treatment persistence during therapeutic sequences with adalimumab and infliximab in the treatment of Crohn's disease
by: Carlos Taxonera, et al.

Clinical features of active tuberculosis that developed during anti-tumor necrosis factor therapy in patients with inflammatory bowel disease
by: Jang Wook Lee, et al.
Published: (2016-04-01)

Is safety infliximab during pregnancy in patients with inflammatory bowel disease? ¿El tratamiento con infliximab es seguro durante el embarazo en pacientes con enfermedad inflamatoria intestinal?
by: Federico Argüelles-Arias, et al.
Published: (2012-02-01)

Infliximab improves quality of life in the short-term in patients with fistulizing Crohn's disease in clinical practice Infliximab mejora la calidad de vida en pacientes con enfermedad de Crohn fistulosa
by: V. Cadahia, et al.
Published: (2004-06-01)

SAFETY PROFILE OF ANTI-TNF THERAPY IN CROHN’S DISEASE MANAGEMENT: A BRAZILIAN SINGLE-CENTER DIRECT RETROSPECTIVE COMPARISON BETWEEN INFLIXIMAB AND ADALIMUMAB
by: Mariella BAU, et al.
Published: (2017-09-01)

Tratamento com infliximabe da doença de Behçet ativa Therapy with infliximab in active Behçet's disease
by: Alexandre Wagner Silva de Souza, et al.
Published: (2005-04-01)

Stopping Anti-TNF in CD Remitters: Cons
by: Taku Kobayashi
Published: (2021-08-01)

Co-existence of relapsing polychondritis and Crohn disease treated successfully with infliximab
by: Hye-In Jung, et al.
Published: (2021-01-01)

Evaluation of Infliximab Effects on Gastrointestinal Bleeding in Crohn’s Disease Using Double-Balloon Endoscopy
by: Manzurul Chowdhury, et al.
Published: (2009-07-01)